Loading asset research
Q3 2026 earnings · Nov 2
Vertex Pharmaceuticals Incorporated Common Stock
VRTXNasdaq · USD · StocksQuote as of · Exchange session not verified$516.34
+0.60%
Today
Next earnings call
Next earnings call
In 45 days
2026-11-02
Fiscal period
Q3 2026
EPS estimate
— / ($4.28 est.)
Revenue estimate
— / (— est.)
Timing
unknown
EPS vs. consensus estimate
- Actual
- Estimate
Q3 24Q1 25Q2 25Q3 25Q 252026-02Q1 26Q2 26
Revenue vs. consensus estimate
- Actual
- Estimate
Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 252026-02
EPS surprise history
Q3 25Q2 26
Beat or met consensus in 100% of the last 4 reported quarters.
Previous reports
Values are converted from USD into your selected display currency. Actuals are drawn from SEC filings (XBRL) and Yahoo statements; estimates and surprises from Nasdaq where available.
| Fiscal period | Report date | Normalized EPS | EPS surprise | Revenue | Rev. surprise | Actions |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 3, 2026 | $4.20 / ($4.15 est.) | +1.20% | 3,333,900,000 (unit unavailable) / (— est.) | — | Source |
| Q1 2026 | May 4, 2026 | $3.95 / ($3.69 est.) | +7.05% | 2,986,900,000 (unit unavailable) / (— est.) | — | Source |
| — | Feb 12, 2026 | $4.65 / (— est.) | — | $3.2B / (— est.) | — | Source |
| Q 2025 | Feb 12, 2026 | $4.65 / ($4.40 est.) | +5.68% | 3,190,000,000 (unit unavailable) / (— est.) | — | Source |
| Q3 2025 | Nov 3, 2025 | $4.22 / ($4.00 est.) | +5.50% | 3,076,400,000 (unit unavailable) / (— est.) | — | Source |
| Q2 2025 | Aug 4, 2025 | $3.99 / (— est.) | — | $3B / (— est.) | — | Source |
| Q1 2025 | May 5, 2025 | $2.49 / (— est.) | — | $2.8B / (— est.) | — | Source |
| Q4 2024 | Feb 10, 2025 | 3.62 (unit unavailable) / (— est.) | — | $2.9B / (— est.) | — | Source |
| Q3 2024 | Nov 4, 2024 | $4.01 / (— est.) | — | $2.8B / (— est.) | — | Source |
| Q2 2024 | Aug 1, 2024 | -$13.92 / (— est.) | — | $2.6B / (— est.) | — | Source |
| Q1 2024 | May 6, 2024 | $4.21 / (— est.) | — | $2.7B / (— est.) | — | Source |
| Q4 2023 | Feb 5, 2024 | 3.71 (unit unavailable) / (— est.) | — | $2.5B / (— est.) | — | Source |
| Q3 2023 | Nov 6, 2023 | $3.97 / (— est.) | — | $2.5B / (— est.) | — | Source |
| Q2 2023 | Aug 1, 2023 | $3.52 / (— est.) | — | $2.5B / (— est.) | — | Source |
| Q1 2023 | May 1, 2023 | $2.69 / (— est.) | — | $2.4B / (— est.) | — | Source |
| Q4 2022 | Feb 7, 2023 | 3.14 (unit unavailable) / (— est.) | — | $2.3B / (— est.) | — | Source |
| Q3 2022 | Oct 27, 2022 | $3.59 / (— est.) | — | $2.3B / (— est.) | — | Source |
| Q2 2022 | Aug 4, 2022 | $3.13 / (— est.) | — | $2.2B / (— est.) | — | Source |
| Q1 2022 | May 5, 2022 | $2.96 / (— est.) | — | $2.1B / (— est.) | — | Source |
| Q4 2021 | Jan 26, 2022 | 2.98 (unit unavailable) / (— est.) | — | $2.1B / (— est.) | — | Source |
| Q3 2021 | Nov 2, 2021 | $3.28 / (— est.) | — | $2B / (— est.) | — | Source |
| Q2 2021 | Jul 29, 2021 | $0.26 / (— est.) | — | $1.8B / (— est.) | — | Source |
| Q1 2021 | Apr 29, 2021 | $2.49 / (— est.) | — | $1.7B / (— est.) | — | Source |
| FY 2020 | Feb 1, 2021 | $2.30 / (— est.) | — | $1.6B / (— est.) | — | Source |
| Q3 2020 | Oct 29, 2020 | $2.53 / (— est.) | — | $1.5B / (— est.) | — | Source |
| Q2 2020 | Jul 30, 2020 | $3.18 / (— est.) | — | $1.5B / (— est.) | — | Source |
| Q1 2020 | Apr 29, 2020 | $2.29 / (— est.) | — | $1.5B / (— est.) | — | Source |
| FY 2019 | Jan 30, 2020 | $2.23 / (— est.) | — | $1.4B / (— est.) | — | Source |
| Q3 2019 | Oct 30, 2019 | $0.22 / (— est.) | — | $949.8M / (— est.) | — | Source |
| Q2 2019 | Jul 31, 2019 | $1.03 / (— est.) | — | $941.3M / (— est.) | — | Source |
| Q1 2019 | Apr 30, 2019 | $1.03 / (— est.) | — | $858.4M / (— est.) | — | Source |
| FY 2018 | Feb 5, 2019 | $5.97 / (— est.) | — | $870.1M / (— est.) | — | Source |
| Q3 2018 | Oct 24, 2018 | $0.50 / (— est.) | — | $784.5M / (— est.) | — | Source |
| Q2 2018 | Jul 25, 2018 | $0.80 / (— est.) | — | $752.2M / (— est.) | — | Source |
| Q1 2018 | Apr 26, 2018 | $0.81 / (— est.) | — | $640.8M / (— est.) | — | Source |
| FY 2017 | Jan 31, 2018 | $0.39 / (— est.) | — | $651.6M / (— est.) | — | Source |
| Q3 2017 | Oct 25, 2017 | -$0.41 / (— est.) | — | $578.2M / (— est.) | — | Source |
| Q2 2017 | Jul 26, 2017 | $0.07 / (— est.) | — | $544.1M / (— est.) | — | Source |
| Q1 2017 | Apr 27, 2017 | $0.99 / (— est.) | — | $714.7M / (— est.) | — | Source |
| FY 2016 | Jan 9, 2017 | $0.13 / (— est.) | — | $458.7M / (— est.) | — | Source |
| Q3 2016 | Oct 25, 2016 | -$0.16 / (— est.) | — | $413.8M / (— est.) | — | Source |
| Q2 2016 | Jul 27, 2016 | -$0.26 / (— est.) | — | $431.6M / (— est.) | — | Source |
| Q1 2016 | May 3, 2016 | -0.17 (unit unavailable) / (— est.) | — | 398,080,000 (unit unavailable) / (— est.) | — | — |
| FY 2015 | Feb 16, 2016 | — / (— est.) | — | 417,935,000 (unit unavailable) / (— est.) | — | — |
| Q3 2015 | Oct 30, 2015 | -0.39 (unit unavailable) / (— est.) | — | 309,816,000 (unit unavailable) / (— est.) | — | — |
| Q2 2015 | Aug 4, 2015 | -0.78 (unit unavailable) / (— est.) | — | 166,076,000 (unit unavailable) / (— est.) | — | — |
| Q1 2015 | May 4, 2015 | -0.83 (unit unavailable) / (— est.) | — | 138,509,000 (unit unavailable) / (— est.) | — | — |
| FY 2014 | Feb 13, 2015 | — / (— est.) | — | 144,556,000 (unit unavailable) / (— est.) | — | — |
| Q3 2014 | Nov 6, 2014 | -0.72 (unit unavailable) / (— est.) | — | 178,987,000 (unit unavailable) / (— est.) | — | — |
| Q2 2014 | Jul 31, 2014 | -0.68 (unit unavailable) / (— est.) | — | 138,421,000 (unit unavailable) / (— est.) | — | — |
| Q1 2014 | May 5, 2014 | -1 (unit unavailable) / (— est.) | — | 118,451,000 (unit unavailable) / (— est.) | — | — |
| FY 2013 | Feb 11, 2014 | 0.19 (unit unavailable) / (— est.) | — | 351,157,000 (unit unavailable) / (— est.) | — | — |
| Q3 2013 | Nov 7, 2013 | -0.54 (unit unavailable) / (— est.) | — | 221,700,000 (unit unavailable) / (— est.) | — | — |
| Q2 2013 | Aug 2, 2013 | -0.26 (unit unavailable) / (— est.) | — | 310,750,000 (unit unavailable) / (— est.) | — | — |
| Q1 2013 | May 8, 2013 | -1.43 (unit unavailable) / (— est.) | — | 328,368,000 (unit unavailable) / (— est.) | — | — |
| FY 2012 | Mar 1, 2013 | -0.35 (unit unavailable) / (— est.) | — | 333,994,000 (unit unavailable) / (— est.) | — | — |
| Q3 2012 | Nov 6, 2012 | -0.27 (unit unavailable) / (— est.) | — | 336,006,000 (unit unavailable) / (— est.) | — | — |
| Q2 2012 | Aug 8, 2012 | -0.31 (unit unavailable) / (— est.) | — | 418,305,000 (unit unavailable) / (— est.) | — | — |
| Q1 2012 | May 10, 2012 | 0.43 (unit unavailable) / (— est.) | — | 438,737,000 (unit unavailable) / (— est.) | — | — |
| FY 2011 | Feb 22, 2012 | 0.74 (unit unavailable) / (— est.) | — | 563,340,000 (unit unavailable) / (— est.) | — | — |
| Q3 2011 | Nov 3, 2011 | 1.02 (unit unavailable) / (— est.) | — | 659,200,000 (unit unavailable) / (— est.) | — | — |
| Q2 2011 | Aug 9, 2011 | -0.85 (unit unavailable) / (— est.) | — | 114,424,000 (unit unavailable) / (— est.) | — | — |
| Q1 2011 | May 6, 2011 | -0.87 (unit unavailable) / (— est.) | — | 73,662,000 (unit unavailable) / (— est.) | — | — |
| FY 2010 | Feb 17, 2011 | -0.9 (unit unavailable) / (— est.) | — | 65,524,000 (unit unavailable) / (— est.) | — | — |
| Q3 2010 | Oct 28, 2010 | -1.04 (unit unavailable) / (— est.) | — | 23,795,000 (unit unavailable) / (— est.) | — | — |
| Q2 2010 | Aug 3, 2010 | -1 (unit unavailable) / (— est.) | — | 31,622,000 (unit unavailable) / (— est.) | — | — |
| Q1 2010 | May 3, 2010 | -0.83 (unit unavailable) / (— est.) | — | 22,429,000 (unit unavailable) / (— est.) | — | — |
Regulatory filings
Company reports filed with the SEC.